ArticleThe Prostate2022

Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling.

J Matthijs Moll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.